# Impact of Circadian Rhythm on Immunotherapy

> **NCT07224971** · PHASE2 · RECRUITING · sponsor: **Liza Villaruz, MD** · enrollment: 350 (estimated)

## Conditions studied

- Advanced/Metastatic NSCLC

## Interventions

- **DRUG:** Immunotherapy - PD-1 Blocker

## Key facts

- **NCT ID:** NCT07224971
- **Lead sponsor:** Liza Villaruz, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-02
- **Primary completion:** 2027-05-01
- **Final completion:** 2030-05-01
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07224971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07224971, "Impact of Circadian Rhythm on Immunotherapy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07224971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*